Briteseed
Chicago, US · Founded 2013 · 14 employees on LinkedIn · 1 known investors
Briteseed develops hyperspectral imaging technology integrated into laparoscopic and robotic surgical instruments to provide real-time visualization of critical anatomical structures during surgery. The company produces a suite of surgical tools including energy, stapler, and dissection instruments that display information on existing operating room monitors to improve surgical safety and outcomes.
Founders & leadership
Investors · 1
Reported raises · per SEC filings
Form D private placements$690K disclosed across 1 round · 2013
▶$690KraisedJan 2014 · 15 investors · Other Health Care
- Paul Albert FehrenbacherExecutive Officer, Director
- Jonathan Whitney GunnExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $690K
- Minimum investment
- $25K
- First sale
- Apr 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $497.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.4M |
| National Science Foundation | Phase II | 2017 | $750K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $274.9K |
| National Science Foundation | Phase I | 2015 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Briteseed do?
- Briteseed develops hyperspectral imaging technology integrated into laparoscopic and robotic surgical instruments to provide real-time visualization of critical anatomical structures during surgery. The company produces a suite of surgical tools including energy, stapler, and dissection instruments that display information on existing operating room monitors to improve surgical safety and outcomes.
- Who are Briteseed's investors?
- Briteseed's investors include TMC Venture Fund.
- How much funding has Briteseed raised?
- Briteseed has disclosed $690K raised across 1 round.
- Where is Briteseed headquartered?
- Briteseed is headquartered in Chicago, US.